OSTEONECROSIS
Clinical trials for OSTEONECROSIS explained in plain language.
Never miss a new study
Get alerted when new OSTEONECROSIS trials appear
Sign up with your email to follow new studies for OSTEONECROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection aims to halt bone death in steroid users
Disease control OngoingThis study tests an investigational drug called RAB001 in people with early-stage bone death (osteonecrosis) of the hip caused by long-term steroid use. About 160 participants will receive one of three doses of RAB001 by injection or a standard oral medication (alendronate). The …
Matched conditions: OSTEONECROSIS
Phase: PHASE2 • Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. • Aim: Disease control
Last updated May 26, 2026 04:51 UTC
-
New shoulder implant tracked for 10 years in 67 patients
Disease control OngoingThis study follows 67 people who received a T.E.S.S. V3 shoulder implant to treat conditions like arthritis, fractures, or rotator cuff tears. Researchers will check how long the implant lasts and track any side effects over 10 years. The goal is to confirm the device is safe and…
Matched conditions: OSTEONECROSIS
Sponsor: Zimmer Biomet • Aim: Disease control
Last updated May 26, 2026 04:46 UTC
-
New bone graft combo aims to halt hip collapse in early osteonecrosis
Disease control OngoingThis study tests whether a bone graft substitute called Genex, combined with core decompression and bone marrow concentrate, can help regrow bone and prevent hip collapse in people with early-stage osteonecrosis (bone death) of the femoral head. Twenty-two adults with this condit…
Matched conditions: OSTEONECROSIS
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated May 18, 2026 12:01 UTC